Highlights of the Year in JACC 2006

Journal of the American College of Cardiology

Volumn 49, Issue 4, 2007, Pages 509-527

  DeMaria, Anthony N ^a   Ben Yehuda, Ori ^a   Feld, Gregory K ^a   Ginsburg, Geoffrey S ^d   Greenberg, Barry H ^a   Lew, Wilbur Y W ^b   Lima, Joao A C ^e   Maisel, Alan S ^b   Narula, Jagat ^c   Sahn, David J ^f   Tsimikas, Sotirios ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMIODARONE; AMLODIPINE; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BIOLOGICAL MARKER; CAPTOPRIL; DILTIAZEM; HIGH DENSITY LIPOPROTEIN; INOSINE; IODIXANOL; IOXAGLIC ACID; NATRIURETIC FACTOR; PLACEBO; POLYUNSATURATED FATTY ACID; RANOLAZINE; RAPAMYCIN; RAPAMYCIN DERIVATIVE; SOTALOL; STATIN; TRASTUZUMAB; TRIMETAZIDINE; UNCLASSIFIED DRUG; ZOTAROLIMUS;

AORTA STENOSIS; ATHEROSCLEROSIS; BREAST CANCER; CARDIOMYOPATHY; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; DRUG ELUTING STENT; GENOMICS; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT ATRIUM PRESSURE; HEART VALVE; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; ISCHEMIA; KIDNEY FAILURE; MICROANGIOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STABLE ANGINA PECTORIS; SUDDEN DEATH; SURGICAL RISK; SYSTOLIC DYSFUNCTION; UNSPECIFIED SIDE EFFECT;

CARDIOLOGY; CORONARY ARTERIOSCLEROSIS; DRUG DELIVERY SYSTEMS; ECHOCARDIOGRAPHY; HEART DEFECTS, CONGENITAL; HUMANS; STENTS;

EID: 33846445252     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.12.008     Document Type: Review

References (139)

1. Hoffmann R., von Bardeleben S., Kasprzak J.D., et al. Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography. J Am Coll Cardiol 47 (2006) 121-128
2. Bolger A.F. Do you see what I see?. J Am Coll Cardiol 47 (2006) 129-130
3. Jeetley P., Hickman M., Kamp O., et al. Myocardial contrast echocardiography for the detection of coronary artery stenosis. A prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol 47 (2006) 141-145
4. Feinstein S.B. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol 48 (2006) 236-243
5. Kadem L., Rieu R., Dumesnil J.G., Durand L.G., and Pibarot P. Flow-dependent changes in Doppler-derived aortic valve effective orifice area are real and not due to artifact. J Am Coll Cardiol 47 (2006) 131-137
6. Baumgartner H. Hemodynamic assessment of aortic stenosis. J Am Coll Cardiol 47 (2006) 138-140
7. Skulstad H., Urheim S., Edvardsen T., et al. Grading of myocardial dysfunction by tissue Doppler echocardiography. J Am Coll Cardiol 47 (2006) 1672-1682
8. Amundsen B.H., Helle-Valle T., Edvardsen T., et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography. J Am Coll Cardiol 47 (2006) 789-793
9. Tsang T.S.M., Abhayaratna W.P., Barnes M.E., et al. Prediction of cardiovascular outcomes with left atrial size. J Am Coll Cardiol 47 (2006) 1018-1023
10. Osranek M., Fatema K., Qaddoura F., et al. Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 48 (2006) 779-786
11. Manning W.J., and Gelfand E.V. Left atrial size and postoperative atrial fibrillation: the volume of evidence suggests it is time to break an old habit. J Am Coll Cardiol 48 (2006) 787-789
12. Sano K., Kawasaki M., Ishihara Y., et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol 47 (2006) 734-741
13. Nasu K., Tsuchikane E., Katoh O., et al. Accuracy of in vivo coronary plaque morphology assessment. J Am Coll Cardiol 47 (2006) 2405-2412
14. Meissner I., Khandheria B.K., Heit J.A., et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol 47 (2006) 440-445
15. Meier B. Patent foramen ovale, guilty but only as a gang member and for a lesser crime. J Am Coll Cardiol 47 (2006) 446-448
16. Wong C.Y., O'Moore-Sullivan T., Leano R., Hukins C., Jenkins C., and Marwick T.H. Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol 47 (2006) 611-616
17. Chinali M., de Simone G., Roman M.J., et al. Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. J Am Coll Cardiol 47 (2006) 2267-2273
18. von Haehling S., Doehner W., and Anker S.D. Obesity and the heart. J Am Coll Cardiol 47 (2006) 2274-2276
19. Shivalkar B., Van De Heyning C., Kerremans M., et al. Obstructive sleep apnea syndrome. J Am Coll Cardiol 47 (2006) 1433-1439
20. Kandzari D.E., Leon M.B., Popma J.J., et al., ENDEAVOR III Investigators. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 2440-2447
21. Ong A.T.L., van Domburg R.T., Aoki J., Sonnenschein K., Lemos P.A., and Serruys P.W. Sirolimus-eluting stents remain superior to bare-metal stents at two years: medium-term results from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol 47 (2006) 1356-1360
22. Weisz G., Leon M.B., Holmes J., et al. Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. J Am Coll Cardiol 47 (2006) 1350-1355
23. Pinto D.S., Stone G.W., Ellis S.G., et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol 48 (2006) 32-36
24. Kelbaek H., Thuesen L., Helqvist S., et al. The Stenting Coronary Arteries in Non-stress/benestent Disease Trial (SCANDSTENT). J Am Coll Cardiol 47 (2006) 449-455
25. Saia F., Piovaccari G., Manari A., et al. Clinical outcomes for sirolimus-eluting stents and polymer-coated paclitaxel-eluting stents in daily practice: results from a large multicenter registry. J Am Coll Cardiol 48 (2006) 1312-1318
26. Wessely R., Schomig A., and Kastrati A. Sirolimus and paclitaxel on polymer-based drug-eluting stents: similar but different. J Am Coll Cardiol 47 (2006) 708-714
27. Rodriguez A.E., Granada J.F., Rodriguez-Alemparte M., et al. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the prospective, Randomized Oral Rapamycin in Argentina (ORAR II) study. J Am Coll Cardiol 47 (2006) 1522-1529
28. Vermeersh P., Agostoni P., Verheye S., et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC trial. J Am Coll Cardiol 48 (2006) 2426-2431
29. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
30. Nebeker J.R., Virmani R., Bennett C.L., et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 47 (2006) 175-181
31. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111
32. Rodriguez A.E., Mieres J., Fernandez-Pereira C., et al. Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial. J Am Coll Cardiol 47 (2006) 205-207
33. Bakhai A., Stone G.W., Mahoney E., et al. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV trial. J Am Coll Cardiol 48 (2006) 253-261
34. Elezi S., Dibra A., Folkerts U., et al. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease. J Am Coll Cardiol 48 (2006) 262-267
35. Vaitkus P.T. Common sense, dollars and cents, and drug-eluting stents. J Am Coll Cardiol 48 (2006) 268-269
36. Alfonso F., Perez-Vizcayno M.J., Hernandez R., et al. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 47 (2006) 2152-2160
37. Liistro F., Fineschi M., Angioli P., et al. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) registry. J Am Coll Cardiol 48 (2006) 270-275
38. Valgimigli M., Malagutti P., Aoki J., et al. Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis. J Am Coll Cardiol 47 (2006) 507-514
39. Valgimigli M., Malagutti P., Rodriguez-Granillo G.A., et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) registries. J Am Coll Cardiol 47 (2006) 1530-1537
40. Price M.J., Cristea E., Sawhney N., et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol 47 (2006) 871-877
41. Lee M.S., Kapoor N., Jamal F., et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 47 (2006) 864-870
42. Baim D.S., Mauri L., and Cutlip D.C. Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery?. J Am Coll Cardiol 47 (2006) 878-881
43. Gyenes G., Shrive F.M., Graham M.M., Ghali W.A., and Knudtson M.L. The prognostic importance of nonsignificant left main coronary artery disease in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 48 (2006) 276-280
44. Safian R.D., Bresnahan J.F., Jaff M.R., et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 47 (2006) 2384-2389
45. Clark D.J., Lessio S., O'Donoghue M., Tsalamandris C., Schainfeld R., and Rosenfield K. Mechanisms and predictors of carotid artery stent restenosis: a serial intravascular ultrasound study. J Am Coll Cardiol 47 (2006) 2390-2396
46. Zeller T., Rastan A., Sixt S., et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 48 (2006) 1573-1578
47. De Bruyne B., Manoharan G., Pijls N.H.J., et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 48 (2006) 1851-1855
48. Manoharan G., Pijls N.H.J., Lameire N., et al. Assessment of renal flow and flow reserve in humans. J Am Coll Cardiol 47 (2006) 620-625
49. Cribier A., Eltchaninoff H., Tron C., et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 47 (2006) 1214-1223
50. Jo S.H., Youn T.J., Koo B.K., et al. Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 48 (2006) 924-930
51. McCullough P.A., Bertrand M.E., Brinker J.A., and Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 48 (2006) 692-699
52. Stone P.H., Gratsiansky N.A., Biokhin A., Huang I.Z., Meng L., and ERICA Investigators. Antianginal efficacy of ranolazine when added to treatment with amiodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol 48 (2006) 566-575
53. Cairns J.A. Ranolazine: augmenting the antianginal armamentarium. J Am Coll Cardiol 48 (2006) 576-578
54. Pereira A.C., Lopes N.H., Soares P.R., et al. Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II). J Am Coll Cardiol 48 (2006) 954-955
55. Ben-Yehuda O. Physician judgment in cardiology: the art of medicine lives on. J Am Coll Cardiol 48 (2006) 954-955
56. Poldermans D., Bax J.J., Schouten O., et al., Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?. J Am Coll Cardiol 48 (2006) 964-969
57. Kirtane A.J., Piazza G., Murphy S.A., et al., TIMI Study Group. Correlates of bleeding events among moderate-to-high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. J Am Coll Cardiol 47 (2006) 2374-2379
58. Bajaj M., and Ben-Yehuda O. A big fat wedding: association of adiponectin with coronary vascular lesions. J Am Coll Cardiol 48 (2006) 1163-1165
59. Otsuka F., Sugiyama S., Kojima S., et al. Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 48 (2006) 1155-1162
60. Koenig W., Khuseyinova N., Baumert J., Meisinger C., and Lowel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: Results from the 18 year follow-up of a large cohort from Southern Germany. J Am Coll Cardiol 48 (2006) 1369-1377
61. McKenney J.M., Davidson M.H., Shear C.L., and Revkin J.H. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin. J Am Coll Cardiol 48 (2006) 1782-1790
62. Davidson M.H., McKenney J.M., Shear C.L., and Revkin J.H. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels. J Am Coll Cardiol 48 (2006) 1774-1781
63. Barter P.J., and Kastelein J.J. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease. J Am Coll Cardiol 47 (2006) 492-499
64. Milani R.V., and Lavie C.J. Cholesteryl ester transfer protein inhibition: the next frontier in combating coronary artery disease?. J Am Coll Cardiol 48 (2006) 1791-1792
65. Nicholls S.J., Lundman P., Harmer J.A., et al. Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. J Am Coll Cardiol 48 (2006) 715-720
66. Exner M., Minar E., Miekusch W., et al. Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol. J Am Coll Cardiol 47 (2006) 2212-2218
67. Radaelli A., Cazzaniga M., Viola A., et al. Enhanced baroreceptor control of the cardiovascular system by polyunsaturated fatty acids in heart failure patients. J Am Coll Cardiol 48 (2006) 1600-1606
68. Olsson L.G., Swedberg K., Ducharme A., et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction. Results from the Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program. J Am Coll Cardiol 47 (2006) 1997-2004
69. Sola S., Mir M., Lerakis S., Tandon N., and Khan B. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J of Am Coll Cardiol 47 (2006) 332-337
70. Bleske B.E., Nicklas J., Bard R., et al. Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with nonischemic cardiomyopathy and average low-density lipoprotein level. J Am Coll Cardiol 47 (2006) 338-341
71. Ramasubbu K., and Mann D. The emerging role of statins in the treatment of heart failure?. J Am Coll Cardiol 47 (2006) 342-344
72. Lopez B., Gonzalez A., Querejeta R., Larman M., and Diez J. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. J Am Coll Cardiol 48 (2006) 89-96
73. Shirwany A., and Weber K. Extracellular matrix remodeling in hypertensive heart disease?. J Am Coll Cardiol 48 (2006) 97-98
74. Hudson M., Armstrong P., Ruzyllo W., et al. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction. Results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. J Am Coll Cardiol 48 (2006) 15-20
75. Fragasso G., Palloshi A., Puccetti P., et al. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J Am Coll Cardiol 48 (2006) 992-998
76. Tang W.H. Metabolic approach in heart failure: rethinking how we translate from theory to clinical practice. J Am Coll Cardiol 48 (2006) 999-1000
77. Goldenberg I., Moss A.J., McNitt S., et al., MADIT-II Investigators. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 47 (2006) 1811-1817
78. Kakish A., Schaechter A., Subacius H., et al. Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol 47 (2006) 2477-2482
79. Ypenburg C., van Erven L., Bleeker G.B., et al. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias. J Am Coll Cardiol 48 (2006) 464-470
80. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
81. Chow T., Kereiakes D.J., Bartone C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
82. Kaufman E.S., Bloomfield D.M., Steinman R.C., et al. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 48 (2006) 1399-1404
83. Stecker E.C., Vickers C., Waltz J., et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 47 (2006) 1161-1166
84. Straus S.M., Kors J.A., De Bruin M.L., et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 47 (2006) 362-367
85. Vyas A.K., Guo H., Moss A.J., et al., MADIT-II Research Group. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Tiral (MADIT)-II. J Am Coll Cardiol 47 (2006) 769-773
86. Goldberger J.J., Subacius H., Schaechter A., et al., DEFINITE Investigators. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1228-1233
87. Calo L., Lamberti F., Loricchio M.L., et al. Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation: a prospective and randomized study. J Am Coll Cardiol 47 (2006) 2504-2512
88. Singh S.N., Tang X.C., Singh B.N., et al., SAFE-T Investigators. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program substudy. J Am Coll Cardiol 48 (2006) 731-733
89. Gasparini M., Auricchio A., Regoli F., et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48 (2006) 744-746
90. Hayes J.J., Sharma A.D., Love J.C., Herre J.M., Leonen A.O., Kudenchuk P.J., and DAVID Investigators. Abnormal conduction increases risk of adverse outcomes from right ventricular pacing. J Am Coll Cardiol 48 (2006) 1628-1633
91. Leber A.W., Becker A., Knez A., et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J Am Coll Cardiol 47 (2006) 672-677
92. Hamon M., Biondi-Zoccai G.G.L., Malagutti P., et al. Diagnostic performance of multislice spiral computed tomography of coronary arteries as compared with conventional invasive coronary angiography: a meta-analysis. J Am Coll Cardiol 48 (2006) 1896-1910
93. Hausleiter J., Meyer T., Hadamitzky M., Kastrati A., Martinoff S., and Schömig A. Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. J Am Coll Cardiol 48 (2006) 312-318
94. Ghostine S., Caussin C., Daoud B., et al. Non-invasive detection of coronary artery disease in patients with left bundle branch block using 64-slice computed tomography. J Am Coll Cardiol 48 (2006) 1929
95. Iskandrian A.E. Detecting coronary artery disease in left bundle branch block. J Am Coll Cardiol 48 (2006) 1935-1937
96. Gilard M., Cornily J.C., Pennec P.Y., et al. Accuracy of multislice computed tomography in the preoperative assessment of coronary disease in patients with aortic valve stenosis. J Am Coll Cardiol 47 (2006) 2020-2024
97. Hoffmann U., and Shapiro M. Coronary multidetector computed tomography: a new standard for preoperative risk assessment?. J Am Coll Cardiol 47 (2006) 2025-2026
98. Baks T., Cademartiri F., Moelker A.D., et al. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction. J Am Coll Cardiol 48 (2006) 144-152
99. George R.T., Silva C., Cordeiro M.A.S., et al. Multidetector computed tomography myocardial perfusion imaging during adenosine stress. Am Coll Cardiol 48 (2006) 153-160
100. Barbie C.E., Bjerner T., Johansson L., Lind L., and Ahlström H. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol 48 (2006) 765-771
101. Wang L., Jerosch-Herold M., Jacobs Jr. D.R., Shahar E., Detrano R., Folsom A.R., and MESA Study Investigators. Coronary artery calcification and myocardial perfusion in asymptomatic adults: the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 48 (2006) 1018-1026
102. Fernandes V.R.S., Polak J.F., Edvardsen T., et al. Subclinical atherosclerosis and incipient regional myocardial dysfunction in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 47 (2006) 2420-2428
103. White J.A., Yee R., Yuan X., et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 48 (2006) 1953-1960
104. Sakuma H., Ichikawa Y., Chino S., Hirano T., Makino K., and Taked K. Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 48 (2006) 1946-1950
105. de Cobelli F., Pieroni M., Esposito A., et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 47 (2006) 1649-1654
106. Assomull R.G., Prasad S.K., Lyne J., et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1977-1985
107. Yoshinaga K., Chow B.J.W., Williams K., et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography?. J Am Coll Cardiol 48 (2006) 1029-1039
108. Wagner B., Anton M., Nekolla S.G., et al. Noninvasive characterization of myocardial molecular interventions by integrated positron emission tomography and computed tomography. J Am Coll Cardiol 48 (2006) 2107-2115
109. Sangiorgi G., Mauriello A., Bonanno E., et al. Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J Am Coll Cardiol 47 (2006) 2201-2211
110. Waxman D.A., Hecht S., Schappert J., and Husk G. A model for troponin I as a quantitative predictor of in-hospital mortality. J Am Coll Cardiol 48 (2006) 1755-1762
111. Jaffe A.S. Chasing troponin: how low can you go if you can see the rise?. J Am Coll Cardiol 48 (2006) 1763-1764
112. Tsutamoto T., Wada A., Sakai H., et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 47 (2006) 582-586
113. Schnabel R., Lubos E., Rupprecht H.J., et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene Study. J Am Coll Cardiol 47 (2006) 552-558
114. Rossi G.P., Bernini G., Caliumi C., et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48 (2006) 2293-2300
115. Jux C., Bertram H., Wohlsein P., Bruegmann M., and Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol 48 (2006) 161-169
116. Tzifa A., Ewert P., Brzezinska-Rajszys G., et al. Covered cheatham-platinum stents for aortic coarctation: early and intermediate-term results. J Am Coll Cardiol 47 (2006) 1457-1463
117. Li J., Zhang G., Holtby H., et al. Adverse effects of dopamine on systemic hemodynamic status and oxygen transport in neonates after the Norwood Procedure. J Am Coll Cardiol 48 (2006) 1859-1864
118. Losay J., Touchot A., Capderou A., et al. Aortic valve regurgitation after arterial switch operation for transposition of the great arteries: incidence, risk factors, and outcome. J Am Coll Cardiol 47 (2006) 2057-2062
119. del Nido J.P., and Schwartz M.L. Aortic regurgitation after atrial switch operation. J Am Coll Cardiol 47 (2006) 2063-2064
120. Cheung M.M.H., Kharbanda R.K., Konstantinov I.E., et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 48 (2006) 2277-2282
121. Senzaki H., Masutani S., Ishido H., et al. Cardiac rest and reserve function in patients with Fontan circulation. J Am Coll Cardiol 47 (2006) 2528-2535
122. Montero I., Orbe J., Varo N., et al. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47 (2006) 1369-1378
123. Jialal I., Devaraj S., and Singh U. C-reactive protein and the vascular endothelium: implications for plaque instability. J Am Coll Cardiol 47 (2006) 1379-1381
124. Marfella R., D'Amico M., Di Filippo C., et al. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosigilitazone treatment. J Am Coll Cardiol 47 (2006) 2444-2455
125. Liu S.L., Li Y.H., Shi G.Y., et al. A novel inhibitory effect of naloxone on macrophage activation and atherosclerosis formation in mice. J Am Coll Cardiol 48 (2006) 1871-1879
126. Liu X., Gu X., Li Z., et al. Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol 48 (2006) 1438-1447
127. Freedman N.J., and Ginsburg G.S. Novel-and "neu"-therapeutic possibilities for heart failure. J Am Coll Cardiol 48 (2006) 1448-1450
128. Anversa P., Leri A., and Kajstura J. Cardiac regeneration. J Am Coll Cardiol 47 (2006) 1769-1776
129. Murry C.E., Reinecke H., and Pabon L.M. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol 47 (2006) 1777-1785
130. Ben-Dor I., Fuchs S., and Kornowski R. Potential hazards and technical considerations associated with myocardial cell transplantation protocols for ischemic myocardial syndrome. J Am Coll Cardiol 48 (2006) 1519-1526
131. Zhou R., Acton P., and Ferrari V. Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol 48 (2006) 2094-2106
132. Ginsburg G.S., Donahue M.P., and Newby L.K. Prospects for personalized cardiovascular medicine: the impact of genomics. J Am Coll Cardiol 46 (2005) 1615-1627
133. Donahue M.P., Marchuk D.A., and Rochman H.A. Redefining heart failure: the utility of genomics. J Am Coll Cardiol 48 (2006) 1289-1298
134. Roberts R. Genomics and cardiac arrhythmias. J Am Coll Cardiol 47 (2006) 9-21
135. Podgoreanu M.V., and Schwinn D.A. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. J Am Coll Cardiol 46 (2005) 1965-1977
136. Seo D., Ginsburg G.S., and Goldschmidt-Clermont P.J. Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications. J Am Coll Cardiol 48 (2006) 227-235
137. Jaffer F.A., Libby P., and Weissleder R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol 47 (2006) 1328-1338
138. Arab S., Gramolini A.O., Ping P., et al. Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol 48 (2006) 1733-1741
139. Boos C.J., Lip G.Y., and Blann A.D. Circulating endothelial cells in cardiovascular disease. J Am Coll Cardiol 48 (2006) 1538-1547